|
⚲
|
| Keyboard |
| Glickman Richard M
✚
|
|
|---|---|
| CIK # | 0001352637 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001352637] | |
| 4 | [0001352637] | |
| SC 13D | [0001352637] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Glickman Richard M | ESSA Pharma Inc | [2016-01-25] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Glickman Richard M | |
| enGene Therapeutics Inc | |
| ESSA Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ESSA Pharma Inc EPIX
Common Shares
|
2025-10-09 | Disposed to issuer | 43,240 | ||
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2025-06-16 | Grant | 22,500 | $0.00 | |
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2024-06-15 | Grant | 20,000 | $0.00 | |
|
enGene Therapeutics Inc ENGN
Common Shares
|
2024-05-28 | Option exercise | 120 | $0.89 | 107 |
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2024-05-28 | Option exercise | 120 | $0.00 | |
|
ESSA Pharma Inc EPIX
Common Shares
|
2024-04-24 | Option exercise | 3,750 | $4.90 | 18,375 |
|
ESSA Pharma Inc EPIX
Options · derivative
|
2024-04-24 | Option exercise | 3,750 | $0.00 | |
|
ESSA Pharma Inc EPIX
Options · derivative
|
2024-03-25 | Grant | 70,000 | $0.00 | |
|
enGene Therapeutics Inc ENGN
Common Shares
|
2023-10-31 | Grant | 24,555 | ||
|
ESSA Pharma Inc EPIX
Stock Option (Right to Buy) · derivative
|
2022-06-29 | Grant | 35,000 | $0.00 | |
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2021-08-20 | Grant | 14,205 | ||
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2021-08-20 | Grant | 12,001 | ||
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2020-12-14 | Grant | 12,032 | ||
|
ESSA Pharma Inc EPIX
Stock Option (Right to Buy) · derivative
|
2020-12-11 | Grant | 25,000 | $0.00 | |
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2018-03-16 | Grant | 4,123 | ||
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2017-06-15 | Grant | 3,188 | ||
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2016-01-11 | Grant | 9,023 | ||
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2015-05-21 | Grant | 11,189 | ||
|
enGene Therapeutics Inc ENGN
Stock Option (Right to Buy) · derivative
|
2013-12-04 | Grant | 120 |